Skip to main content
SpringerLink
Log in
Book cover

Prostate Cancer pp 179–199Cite as

Radiation Therapy in Prostate Cancer

  • Chapter

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 175))

Abstract

Adenocarcinoma of the prostate is one of the most frequently diagnosed cancers of men in the Western hemisphere and is second only to lung cancer for male cancer mortality. Most patients are diagnosed in the early/clinically localized stage, which can be treated curatively with radiation therapy alone. Innovative methods such as brachytherapy, three-dimensional conformal radiotherapy (3D-CRT), and IMRT (intensity modulated radiotherapy) are able to deliver very high tumoricidal doses to the diseased prostate, with minimal side effects to the surrounding tissue. Radiation therapy combined with hormonal treatment can be curative in locally advanced disease. Radiation therapy is also very effective in alleviating symptoms of metastatic prostate cancer (bone metastases, spinal cord compression, and bladder outlet obstruction).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anscher MS, Robertson CN, Prosnitz R (1995) Adjuvant radiotherapy for pathologic stage T3/T4 adenocarcinoma of the prostate: ten-year update. Int J Radiat Oncol Biol Phys 33:37–43

    Article  PubMed  CAS  Google Scholar 

  • Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z (2005) Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63:765–771

    Article  PubMed  Google Scholar 

  • Barringer BS (1917) Radium in the treatment of carcinoma of the bladder and prostate. JAMA 68:1227

    Google Scholar 

  • Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, Catton P, Crook J, Gospodarowicz MK, McLean M, Milosevic M, Warde P (2004) A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 70:37–44

    Article  PubMed  Google Scholar 

  • Beyer DC (1999) Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54:880–883

    Article  PubMed  CAS  Google Scholar 

  • Beyer DC (2001) The evolving role of prostate brachytherapy. Cancer Control 8:163–170

    PubMed  CAS  Google Scholar 

  • Beyer DC (2003) Brachytherapy for recurrent prostate cancer after radiation therapy. Semin Radiat Oncol 13:158–165

    Article  PubMed  Google Scholar 

  • Blanco AI, Michalski JM (2003) Dose escalation in locally advanced carcinoma of the prostate. Semin Radiat Oncol 13:87–97

    Article  PubMed  Google Scholar 

  • Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295–300

    Article  PubMed  CAS  Google Scholar 

  • Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M (2002) Longterm results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360:103–108

    Article  PubMed  CAS  Google Scholar 

  • Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Marechal JM, Scalliet P, Haustermans K, Pierart M, European Organization for Research and Treatment of Cancer (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366:572–578

    Article  PubMed  Google Scholar 

  • Borghede G, Hedelin H, Holmang S, Johansson KA, Aldenborg F, Pettersson S, Sernbo G, Wallgren A, Mercke C (1997) Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol 44:237–244

    Article  PubMed  CAS  Google Scholar 

  • Brassell SA, Rosner IL, McLeod DG (2005) Update on magnetic resonance imaging, ProstaScint, and novel imaging in prostate cancer. Curr Opin Urol 15:163–166

    Article  PubMed  Google Scholar 

  • Brenner DJ, Hall EJ (1999) Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43:1095–1101

    Article  PubMed  CAS  Google Scholar 

  • Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP (2002) Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to lateresponding normal tissue. Int J Radiat Oncol Biol Phys 52:6–13

    Article  PubMed  Google Scholar 

  • Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH (1999) Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 54:346–351

    Article  PubMed  CAS  Google Scholar 

  • Chou JL, Easley JD, Feldmeier JJ, Rauth VA, Pomeroy TC (1988) Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy. Int J Radiat Oncol Biol Phys 15:749–751

    PubMed  CAS  Google Scholar 

  • Collette L, van Poppel H, Bolla M, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, Pierart M, for the European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy and Genito-urinary Groups (2005) Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). Eur J Cancer 41:2662–2672

    Article  PubMed  Google Scholar 

  • D’Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Tomaszewski JE, Wein A (1998) The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 162:2096–2101

    Article  Google Scholar 

  • D’Amico AV, Manola J, Loffredo M, Renshaw AA, Della Croce A, Kantoff PW (2004) 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 292:821–827

    Article  PubMed  CAS  Google Scholar 

  • de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62:965–973

    Article  PubMed  Google Scholar 

  • Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, Yarnold J, Horwich A (1999) Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353:267–272

    Article  PubMed  CAS  Google Scholar 

  • Di Lorenzo G, Autorino R, Perdona S, De Placido S (2005) Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet 6:972–979

    Article  Google Scholar 

  • Duncan W, Warde P, Catton CN, Munro AJ, Lakier R, Gadalla T, Gospodarowicz MK (1993) Carcinoma of the prostate: results of radical radiotherapy (1970-1985). Int J Radiat Oncol Biol Phys 26:203–210

    PubMed  CAS  Google Scholar 

  • Flocks RH, Kerr HD, Elkins HB, Culp D (1952) Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold (198-Au): a preliminary report. J Urol 68:510–522

    PubMed  CAS  Google Scholar 

  • Fowler J, Chappell R, Ritter M (2001) Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50:1021–1031

    Article  PubMed  CAS  Google Scholar 

  • Fowler JF, Ritter MA, Chappell RJ, Brenner DJ (2003) What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56:1093–1104

    Article  PubMed  Google Scholar 

  • Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, Larson TR, Wilkes MM, Navickis RJ (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53:2–10

    Article  PubMed  CAS  Google Scholar 

  • Hanks GE, Schultheiss TE, Hunt MA, Epstein B (1995) Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 31:25–29

    Article  PubMed  CAS  Google Scholar 

  • Hanks GE, Lee WR, Hanlon AL, Hunt M, Kaplan E, Epstein BE, Movsas B, Schultheiss TE (1996) Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >or = 10 ng/ml. Int J Radiat Oncol Biol Phys 35:861–868

    Article  PubMed  CAS  Google Scholar 

  • Hanks GE, Hanlon AL, Epstein B, Horwitz EM (2002) Dose response in prostate cancer with 8–12 years’ follow-up. Int J Radiat Oncol Biol Phys 54:427–435

    Article  PubMed  Google Scholar 

  • Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group (2003) Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate. The Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 21:3972–3978

    Article  PubMed  CAS  Google Scholar 

  • Hayes SB, Pollack A (2005) Parameters for treatment decisions for salvage radiation therapy. J Clin Oncol 23:8204–8211

    Article  PubMed  Google Scholar 

  • Hilaris BS, Whitmore WF, Batata M, Barzell W (1977) Behavioral patterns of prostate adenocarcinoma following an 125-I implant and pelvic node dissection. Int J Radiat Oncol Biol Phys 2:631–637

    PubMed  CAS  Google Scholar 

  • Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I (1983) Transperineal 125-iodine seed implantation in prostate cancer guided by transrectal ultrasonography. J Urol 130:283–286

    PubMed  CAS  Google Scholar 

  • Hussey DK (1980) Carcinoma of the prostate. In: Fletcher GH (ed) Textbook of radiotherapy (3rd edn). Lea and Febiger, Philadelphia, pp 894–914

    Google Scholar 

  • International Commission on Radiation Units and Measurements (1993) Prescribing, recording, and reporting photon beam therapy. ICRU Report 50. ICRU, Bethesda

    Google Scholar 

  • International Commission on Radiation Units and Measurements (1999) Prescribing, recording, and reporting photon beam therapy. ICRU Report 62. ICRU, Bethesda

    Google Scholar 

  • Joon DL, Hasegawa M, Sikes C, Khoo VS, Terry NH, Zagars GK, Meistrich ML, Pollack A (1997) Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation. Int J Radiat Oncol Biol Phys 38:1071–1078

    Article  PubMed  CAS  Google Scholar 

  • Kagawa K, Lee WR, Schultheiss TE, Hunt MA, Shaer AH, Hanks GE (1997) Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 38:319–325

    Article  PubMed  CAS  Google Scholar 

  • Kestin LL, Martinez AA, Stromberg JS, Edmundson GK, Gustafson GS, Brabbins DS, Chen PY, Vicini FA (2000) Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 18:2869–2880

    PubMed  CAS  Google Scholar 

  • Khan MA, Partin AW (2003) Partin tables: past and present. BJU Int 92:7–11

    Article  PubMed  CAS  Google Scholar 

  • King CR (2000) What is the Tpot for prostate cancer? Radiobiological implications of the equivalent outcome with 125I or 103Pd. Int J Radiat Oncol Biol Phys 47:1165–1167

    Article  PubMed  CAS  Google Scholar 

  • Kirschenbaum A (1995) Management of hormonal treatment effects. Cancer 75:1983–1987

    Article  Google Scholar 

  • Kneebone A, Gebski V, Hogendoorn N, Turner S (2003) A randomized trial evaluating rigid immobilization for pelvic irradiation. Int J Radiat Oncol Biol Phys 56:1105–1111

    Article  PubMed  Google Scholar 

  • Koper PC, Stroom JC, van Putten WL, Korevaar GA, Heijmen BJ, Wijnmaalen A, Jansen PP, Hanssens PE, Griep C, Krol AD, Samson MJ, Levendag PC (1999) Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 43:727–734

    Article  PubMed  CAS  Google Scholar 

  • Kovacs G, Potter R, Loch T, Hammer J, Kolkman-Deurloo IK, de la Rosette JJ, Bertermann H (2005) GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localized prostate cancer. Radiother Oncol 74:137–148

    Article  PubMed  Google Scholar 

  • Kupelian P, Katcher J, Levin H, Zippe C, Klein E (1996) Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 48:249–260

    Article  PubMed  CAS  Google Scholar 

  • Kuten A, Bernstein Z, Nijem R, Schneider J (2004) Prophylactic breast irradiation for bicalutamide-induced gynecomastia. Poster presentation at 2nd ESTRO Meeting on Radiotherapy for Non-Malignant Diseases. Nice, France 1–3 April 2004, S37

    Google Scholar 

  • Lawton CA (2003) Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate. Semin Radiat Oncol 13:141–151

    Article  PubMed  Google Scholar 

  • Lawton CA, Winter K, Murray K, Machtay M, Mesic JB, Hanks GE, Coughlin CT, Pilepich MV (2001) Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys 49:937–946

    Article  PubMed  CAS  Google Scholar 

  • Lea DE (1955) Actions of radiation on living cells (2nd edn.) Cambridge University Press, Cambridge

    Google Scholar 

  • Leibel SA, Hanks GE, Kramer S (1984) Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 10:401–409

    PubMed  CAS  Google Scholar 

  • Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H (2000) Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 163:1178–1182

    Article  PubMed  CAS  Google Scholar 

  • Liu L, Glicksman AS, Coachman N, Kuten A (1997) Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 38:65–71

    Article  PubMed  CAS  Google Scholar 

  • Logue JP, Cowan RA, Hendry JH (2001) Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys 49:1522–1523

    Article  PubMed  CAS  Google Scholar 

  • Mantz CA, Song P, Farhangi E, Nautiyal J, Awan A, Ignacio L, Weichselbaum R, Vijayakumar S (1997) Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int J Radiat Oncol Biol Phys 37:551–557

    Article  PubMed  CAS  Google Scholar 

  • Martinez AA, Gustafson G, Gonzalez J, Armour E, Mitchell C, Edmundson G, Spencer W, Stromberg J, Huang R, Vicini F (2002) Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53:316–327

    Article  PubMed  Google Scholar 

  • McLaughlin PW, Narayana V, Meirovitz A, Troyer S, Roberson PL, Gonda R Jr, Sandler H, Marsh L, Lawrence T, Kessler M (2005a) Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 61:20–31

    Article  PubMed  Google Scholar 

  • McLaughlin PW, Troyer S, Berri S, Narayana V, Meirowitz A, Roberson PL, Montie J (2005b) Functional anatomy of the prostate: implications for treatment planning. Int J Radiat Oncol Biol Phys 63:479–491

    Article  PubMed  Google Scholar 

  • Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD (2000) Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46:391–402

    Article  PubMed  CAS  Google Scholar 

  • Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD (2005) Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 62:706–713

    Article  PubMed  Google Scholar 

  • Nag S, Beyer D, Friedland J, Grimm P, Nath R (1999) American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44:789–799

    Article  PubMed  CAS  Google Scholar 

  • Pasteau O, Degrais P (1914) The radium treatment of the prostate. Arch Roentgenol Ray 18:396

    Google Scholar 

  • Paulson DF, Moul JW, Robertson JE, Walther PJ (1990) Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 143:1178–1182

    PubMed  CAS  Google Scholar 

  • Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC (2005) Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61:1019–1034

    Article  PubMed  Google Scholar 

  • Perez CA, Lee HK, Georgiou A, Logsdon MD, Lai PP, Lockett MA (1993a) Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 26:581–591

    PubMed  CAS  Google Scholar 

  • Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee WR (1993b) Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. Cancer 72:3156–3173

    Article  PubMed  CAS  Google Scholar 

  • Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, Hanks GE, Coughlin CT, Porter A, Shipley WU, Grignon D (1997) Phase III trial of adjuvant androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol 15:1013–1021

    PubMed  CAS  Google Scholar 

  • Pilepich MV, Winter K, John MJ, Mesic JB, Sause W, Rubin P, Lawton C, Machtay M, Grignon D (2001) Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 50:1243–1252

    Article  PubMed  CAS  Google Scholar 

  • Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, Hug EB, Asbell SO, Grignon D (2005) Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 61:1285–1290

    Article  PubMed  CAS  Google Scholar 

  • Pollack A, Zagars GK, Smith LG, Lee JJ, von Eschenbach AC, Antolak JA, Starkschall G, Rosen I (2000) Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18:3904–3911

    PubMed  CAS  Google Scholar 

  • Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE (2004) Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol 171:1132–1136

    Article  PubMed  Google Scholar 

  • Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA Jr (2006) Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 64:518–526

    Article  PubMed  Google Scholar 

  • Ponholzer A, Oismuller R, Somay C, Buchler F, Maier U, Hawliczek R, Rauchenwald M, Madersbacher S (2005) The effect on erectile function of 103-Palladium implantation for localized prostate cancer. BJU Int 95:847–850

    Article  PubMed  CAS  Google Scholar 

  • Read J (1959) Radiation biology of vicia faba in relation to the general problem. Blackwell Scientific, Oxford

    Google Scholar 

  • Roach M 3rd (2003) Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long? J Urol 170:35–41

    Article  Google Scholar 

  • Roach M 3rd (2005) Evidence-based oncology: radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer. Cancer Treat Rev 31:582–586

    Article  PubMed  CAS  Google Scholar 

  • Roach M 3rd, Lu J, Pilepich MV, Asbell SO, Mohiuddin M, Terry R, Grignon D (1999) Long-term survival after radiotherapy alone: radiation therapy oncology group prostate cancer trials. J Urol 161:864–868

    Article  PubMed  Google Scholar 

  • Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti RK, Han S, Thomas CR Jr, Shipley WS, Radiation Therapy Oncology Group 9413 (2003) Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21:1904–1911

    Article  PubMed  Google Scholar 

  • Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, Vijayakumar S, Chen GT (1995) Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 33:1321–1329

    Article  PubMed  CAS  Google Scholar 

  • Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA (2000) Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 48:643–647

    Article  PubMed  CAS  Google Scholar 

  • Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A (2002) CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 75:603–607

    PubMed  CAS  Google Scholar 

  • Seaward SA, Weinberg V, Lewis P, Leigh B, Phillips TL, Roach M 3rd (1998) Improved freedom from PSA failure with whole pelvic irradiation for highrisk prostate cancer. Int J Radiat Oncol Biol Phys 42:1055–1062

    Article  PubMed  CAS  Google Scholar 

  • Shih HA, Harisinghani M, Zietman AL, Wolfgang JA, Saksena M, Weissleder R (2005) Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 63:1262–1269

    Article  PubMed  Google Scholar 

  • Smith GG, Peirson EL (1930) The value of high voltage x-ray therapy in carcinoma of the prostate. J Urol 23:331–342

    Google Scholar 

  • Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I (2000) Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48:635–642

    Article  PubMed  CAS  Google Scholar 

  • Swanson GP, Cupps RE, Utz DC, Ilstrup DM, Zincke H, Myers RP (1994) Definitive therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment. Br J Radiol 67:877–889

    Article  PubMed  CAS  Google Scholar 

  • Swanson GP, Riggs MW, Earle JD (2004) Long-term follow-up of radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 59:406–411

    Article  PubMed  CAS  Google Scholar 

  • Ten Haken RK, Perez-Tamayo C, Tesser RJ, McShan DL, Fraass BA, Lichter AS (1989) Boost treatment of the prostate using shaped, fixed fields. Int J Radiat Oncol Biol Phys 16:193–200

    PubMed  Google Scholar 

  • Tyrrell CJ, Payne H, Tammela TL, Bakke A, Lodding P, Goedhals L, Van Erps P, Boon T, Van De Beek C, Andersson SO, Morris T, Carroll K (2004) Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Biol Phys 60:476–483

    Article  PubMed  Google Scholar 

  • Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Strup S, Petersen RO, Corn BW, Lu JD (1998) Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology 52:1034–1040

    Article  PubMed  CAS  Google Scholar 

  • Valicenti RK, Gomella LG, Perez CA (2003) Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol 13:130–140

    Article  PubMed  Google Scholar 

  • Vicini FA, Vargas C, Edmundson G, Kestin L, Martinez A (2003) The role of high-dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol 13:98–108

    Article  PubMed  Google Scholar 

  • Widman P (1934) Cancer of the prostate. The results of radium and roentgen ray treatment. Radiology 22:153–159

    Google Scholar 

  • Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroyc W, Tekkis PP (2006) Diagnostic precision of nanoparticle-enhanced MRI for lymphnode metastases: a meta-analysis. Lancet Oncol 7:52–60

    Article  PubMed  Google Scholar 

  • Woo S, Kaplan I, Roach M, Bagshaw M (1988) Formula to estimate risk of pelvic lymph node metastasis from the total Gleason score for prostate cancer. J Urol 140:387

    PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Eid JF (1998) Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 40:129–133

    Article  PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES, Leibel SA (1999) Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85:2460–2468

    Article  PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner HE (2000) Five year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47:1261–1266

    Article  PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA (2001) High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166:876–881

    Article  PubMed  CAS  Google Scholar 

  • Zelefsky MJ, Fuks Z, Leibel SA (2002) Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 12:229–237

    Article  PubMed  Google Scholar 

  • Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, Amols H, Venkatraman ES, Leibel SA (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology and Radiation Therapy Rambam Medical Center and Faculty of Medicine, Technion — Israel Institute of Technology, Haifa, Israel

    Moshe E. Stein MD

  2. Charité Campus Mitte Klinik für Strahlentherapie, Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117, Berlin, Germany

    Dirk Boehmer MD

  3. Division of Oncology Rambam Medical Center and Faculty of Medicine, Technion — Israel Institute of Technology, Haifa, Israel

    Abraham Kuten MD

Authors
  1. Moshe E. Stein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dirk Boehmer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abraham Kuten MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, 52621, Israel

    Jacob Ramon MD

  2. Lange Gasthuisstraat 35-37, 2000, Antwerp, Belgium

    Louis J. Denis MD, FACS (Director Oncology Centre Antwerp Secretary Europa Uomo) (Director Oncology Centre Antwerp Secretary Europa Uomo)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stein, M.E., Boehmer, D., Kuten, A. (2007). Radiation Therapy in Prostate Cancer. In: Ramon, J., Denis, L.J. (eds) Prostate Cancer. Recent Results in Cancer Research, vol 175. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-40901-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-40901-4_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40897-0

  • Online ISBN: 978-3-540-40901-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation